These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27727406)

  • 1. Time to change the paradigm of children's medicines from liquid formulations to flexible solid oral dosage forms.
    Hoppu K
    Ceylon Med J; 2016 Sept; 61(3):93-95. PubMed ID: 27727406
    [No Abstract]   [Full Text] [Related]  

  • 2. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Brion F; Nunn AJ; Rieutord A
    Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-centred, administration friendly medicines for children - an evaluation of children's preferences and how they impact medication adherence.
    Bryson SP
    Int J Pharm; 2014 Aug; 469(2):257-9. PubMed ID: 24797763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommended strategies for the oral administration of paediatric medicines with food and drinks in the context of their biopharmaceutical properties: a review.
    Martir J; Flanagan T; Mann J; Fotaki N
    J Pharm Pharmacol; 2017 Apr; 69(4):384-397. PubMed ID: 27704550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage Adjustments Related to Young or Old Age and Organ Impairment.
    Burris JF; Tortorici MA; Mandic M; Neely M; Reed MD
    J Clin Pharmacol; 2016 Dec; 56(12):1461-1473. PubMed ID: 27539787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.
    Venables R; Batchelor H; Stirling H; Marriott J
    Int J Pharm; 2016 Jan; 497(1-2):12-7. PubMed ID: 26611666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric drug formulations: a review of challenges and progress.
    Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
    Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Children's medicines in Tanzania: a national survey of administration practices and preferences.
    Adams LV; Craig SR; Mmbaga EJ; Naburi H; Lahey T; Nutt CT; Kisenge R; Noel GJ; Spielberg SP
    PLoS One; 2013; 8(3):e58303. PubMed ID: 23484012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current administration practices and preferred formulations of children's medicines in Tanzania: summary of survey findings.
    Adams LV; Craig SR; Mmbaga EJ; Naburi H; Lahey T; Kisenge R; Spielberg SP
    Int J Pharm; 2012 Oct; 435(2):150-1. PubMed ID: 22883704
    [No Abstract]   [Full Text] [Related]  

  • 11. Pediatric formulations: international issues and potential solutions.
    Knoppert DC
    Paediatr Drugs; 2009; 11(1):55-6. PubMed ID: 19127956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Drug Formulations - Unintended Consequences of Legislation.
    Probst LA; Welch TR
    N Engl J Med; 2017 Feb; 376(8):795-796. PubMed ID: 28225679
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicines for children: flexible solid oral formulations.
    Orubu ES; Tuleu C
    Bull World Health Organ; 2017 Mar; 95(3):238-240. PubMed ID: 28250539
    [No Abstract]   [Full Text] [Related]  

  • 14. Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements.
    Cilurzo F; Musazzi UM; Franzé S; Selmin F; Minghetti P
    Drug Discov Today; 2018 Feb; 23(2):251-259. PubMed ID: 29030242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosage and method of administration of drugs in childhood.
    Robinson GC; Williams VS
    Practitioner; 1970 Jan; 204(219):5-13. PubMed ID: 5411157
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral drug delivery in personalized medicine: unmet needs and novel approaches.
    Wening K; Breitkreutz J
    Int J Pharm; 2011 Feb; 404(1-2):1-9. PubMed ID: 21070842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues impacting therapeutic outcomes in pediatric patients: an overview.
    Kalra A; Goindi S
    Curr Pediatr Rev; 2014; 10(3):184-93. PubMed ID: 25088338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study.
    Ranmal SR; Cram A; Tuleu C
    Int J Pharm; 2016 Nov; 514(1):296-307. PubMed ID: 27863675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metric medicines.
    Br Med J; 1969 Mar; 1(5643):530. PubMed ID: 5764698
    [No Abstract]   [Full Text] [Related]  

  • 20. How to Modify Drug Release in Paediatric Dosage Forms? Novel Technologies and Modern Approaches with Regard to Children's Population.
    Trofimiuk M; Wasilewska K; Winnicka K
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.